Yes-associated protein 1 exerts its tumor-promoting effects and increases cisplatin resistance in tongue squamous cell carcinoma cells by dysregulating Hippo signal pathway
Authors:
- 21 February 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Anti-Cancer Drugs
- Vol. 33 (4) , 352-361
Abstract
Tongue squamous cell carcinoma (TSCC) has been well-known for its high metastasis and poor prognosis, but the molecular mechanisms of TSCC pathogenesis and chemoresistance are still largely unknown. Thus, the present study aimed to identify the involvement of a classic Hippo/Yes-associated protein 1 (YAP1) pathway in regulating TSCC progression and cisplatin (DDP) resistance. DDP-resistant TSCC cell lines were established by gradual exposure to DDP. Through western blot analysis, the protein expression of Hippo/YAP1 axis in TSCC tissues and cell lines was detected separately. Then, YAP1 was inhibited or overexpressed in TSCC cells. Cell viability and drug resistance were evaluated by cell counting kit-8 method, colony formation assay and Trypan blue staining assay. Cell migration ability was measured by Transwell assay. The Hippo pathway was dysregulated, and YAP1 was upregulated and dephosphorylated in the TSCC tissues or DDP-resistant cell lines, compared with normal tissues or DDP-sensitive cells. YAP1 knockdown inhibited cell proliferation, colony formation ability and migration, whereas overexpression of YAP1 exacerbated these malignant characteristics. YAP1 knockdown increased DDP-sensitivity by reducing the RAD51-mediated DNA damage repair behavior under DDP intervention in the DDP-resistant TSCC cells. Conversely, YAP1 overexpression significantly increased DDP-resistance by enhancing the RAD51-mediated DNA damage repair behavior under DDP intervention in the DDP-sensitive TSCC cells. In a word, upregulation and dephosphorylation of YAP1 caused dysregulation of the tumor-inhibiting Hippo pathway, resulting in the aggressiveness and DDP resistance in TSCC.Keywords
This publication has 52 references indexed in Scilit:
- miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1Molecular Cancer, 2016
- YAP/TAZ at the Roots of CancerCancer Cell, 2016
- Hippo Pathway in Organ Size Control, Tissue Homeostasis, and CancerCell, 2015
- Effects of Rad51 on Survival of A549 CellsAsian Pacific Journal of Cancer Prevention, 2015
- The Hippo pathway in chemotherapeutic drug resistanceInternational Journal of Cancer, 2014
- TCRP1 contributes to cisplatin resistance by preventing Pol β degradation in lung cancer cellsMolecular and Cellular Biochemistry, 2014
- Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic CancerCell, 2014
- Rescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancersNature Medicine, 2014
- Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosisJournal of Oral Pathology & Medicine, 2013
- MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinomaJournal of Human Genetics, 2011